Equibles does not estimate personal net worth.
Get an email with a short summary when Twist Bioscience Corp publishes a filing, an earnings call transcript or a press release.
Get TWST alertsPatrick Finn is recorded as COO at Twist Bioscience Corp (TWST). The newest filing on record that lists Patrick Finn as COO at Twist Bioscience Corp (TWST) is dated January 6, 2026. Twist Bioscience Corp reported in an 8-K filed October 26, 2022 that Patrick Finn was appointed President and Chief Operating Officer, effective October 25, 2022. The proxy statement of Twist Bioscience Corp reports total compensation of $8,022,942 for Patrick Finn in fiscal 2025, including a base salary of $563,000. Disclosed compensation is on record for 7 fiscal years. Patrick Finn has spoken on 9 earnings calls across 1 company, most recently for Twist Bioscience Corp on August 3, 2026. Twist Bioscience Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Twist Bioscience Corp includes Emily Leproust (CEO), Adam Laponis (CFO), Patrick Weiss (COO) and 7 others.
“On October 25, 2022, the Board of Directors of Twist Bioscience Corporation (the "Company") appointed Patrick Finn as President and Chief Operating Officer of the Company, effective immediately.”
“With that, I'd like to turn the call over to Patty, who discuss our competitive mode how we're executing against our priorities and why we believe the operational foundation will build positions twist for its next phase of growth thanks emily good morning everyone one of the things i enjoyed most about investor day is…”
“Halfway through our fiscal year, the results are strong, and we believe the road ahead is stronger. Everything we do in protein solutions and AI-enabled discovery runs on one foundation, our DNA synthesis platform.”
“Going forward, we see meaningful growth ahead as this category continues to develop.”
“As we close fiscal 2025, it's remarkable what we have achieved in the last year, and I'm even more excited about what is to come.”
“I'd like to take a few minutes to dive deeper into how we think about expanding our product portfolio by focusing on our recent launch of gene fragments shipped standard without adapters.”
Start not stated–present
Last confirmed January 6, 2026
Proxy statement
Start not stated–2022-01-04
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
COO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Twist Bioscience Corp (TWST) | President and Chief Operating Officer | $563,000 | $8,022,942 |
| 2024 | Twist Bioscience Corp (TWST) | President and Chief Operating Officer | $500,000 | $3,854,551 |
| 2023 | Twist Bioscience Corp (TWST) | President and Chief Operating Officer | $470,000 | $5,227,858 |
| 2022 | Twist Bioscience Corp (TWST) | President and Chief Operating Officer | $456,000 | $2,690,452 |
| 2021 | Twist Bioscience Corp (TWST) | President and Chief Operating Officer | $427,000 | $726,351 |
| 2020 | Twist Bioscience Corp (TWST) | President and Chief Operating Officer | $417,917 | $2,876,379 |
| 2019 | Twist Bioscience Corp (TWST) | Chief Commercial Officer | $352,917 | $3,013,683 |
